Vera Therapeutics的肾病药物获美国FDA优先审查

格隆汇
Jan 07

美国药物开发商Vera Therapeutics宣布,美国食品和药物管理局(FDA)已对其用于治疗IgA肾病成人患者的实验性药物Atacicept的生物制品许可申请给予优先审查。公司预计FDA将于7月7日做出决定。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10